This content is intended for licensed prescribers and healthcare professionals
Available from: [2] Taskin M
Intravenous glutathione provides the antioxidant directly to your cells by totally avoiding the digestive system
Dr KP Singh, Director of Endocrinology, Fortis Hospital, Mohali and the Principal Investigator of the Semaglutide trial in India, says that the superior glycemic control and weight loss with oral Semaglutide 25 mg and 50 mg compared with the current highest approved dose of 14 mg observed in this landmark study suggest that these higher doses may support individually tailored treatment goals, based not only on glucose-lowering but also body weight and cardiovascular risk reduction targets
This not only supports overall organism energization but also aids in the reduction of body weight
Owing to the scope and aims of the current discussion paper, the in vitro and in vivo preclinical studies are summarised briefly in appendix 1 and include cytotoxicity assessments in a number of primary cells and cell lines and toxicological studies in rats and mice
